Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial - Concepedia

Concepedia

Publication | Open Access

Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial

DOI Full Paper Access

286

Citations

18

References

2017

Year

Yung‐Jue Bang, Rui‐Hua Xu, Keisho Chìn, Keun‐Wook Lee, Se Hoon Park, Sun Young Rha, Lin Shen, Shukui Qin, Nong Xu, Seock‐Ah Im,

The Lancet Oncology

Abstract

AstraZeneca.

References

	Year	Citations

Page 1